Acknowledgements We appreciate the technical support from the Research Support Center, Graduate School of Medical Sciences, Kyushu University and partial support from intramural research funds of NIDDK, NIH
As well as being incredibly useful for many patients with type 2 diabetes, Semaglutide GLP-1 injections are recommended to aid in many cases of weight loss as it helps to reduce body weight, lipids, blood pressure, inflammatory markers, and more in patients receiving medical weight-loss treatment
Standard clinical thresholds commonly used in practice are BMI 30 kg/m or BMI 27 kg/m with obesity-related conditions such as type 2 diabetes, hypertension, or dyslipidemia
GLP-1 drugs like Ozempic, Wegovy, and many others have soared in popularity - first as a treatment for diabetes, and more recently, as an easy way to manage weight
American Journal of Health-System Pharmacy, 78(7), 556-567